Testosterone Replacement in Metabolic Syndrome and Inflammation
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
Hypogonadism (HG) frequently complicates the Metabolic Syndrome (MetS), whether testosterone
replacement (TRT) is beneficial has not been clearly ascertained. This study was designed to
address the effects of TRT on insulin resistance, body composition and pro-inflammatory
status in naïve patients with MetS and HG.